910 related articles for article (PubMed ID: 17342768)
1. Male breast cancer in the veterans affairs population: a comparative analysis.
Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
[TBL] [Abstract][Full Text] [Related]
2. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of two androgen-induced markers (apolipoprotein D and pepsinogen C) in female and male breast carcinoma.
Serra C; Vizoso F; Lamelas ML; Rodríguez JC; González LO; Merino AM; Baltasar A; Pérez-Vázquez MT; Medrano J
Int J Surg Investig; 2000; 2(3):183-92. PubMed ID: 12678518
[TBL] [Abstract][Full Text] [Related]
4. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
[TBL] [Abstract][Full Text] [Related]
5. Similarities and differences in the characteristics and primary treatment of breast cancer in men and women - a population based study (Sweden).
Nilsson C; Holmqvist M; Bergkvist L; Hedenfalk I; Lambe M; Fjällskog ML
Acta Oncol; 2011 Oct; 50(7):1083-8. PubMed ID: 21830994
[TBL] [Abstract][Full Text] [Related]
6. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
7. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.
Grann VR; Troxel AB; Zojwalla NJ; Jacobson JS; Hershman D; Neugut AI
Cancer; 2005 Jun; 103(11):2241-51. PubMed ID: 15844176
[TBL] [Abstract][Full Text] [Related]
8. Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis.
Fields EC; DeWitt P; Fisher CM; Rabinovitch R
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):747-52. PubMed ID: 24138917
[TBL] [Abstract][Full Text] [Related]
9. Association of surgery with improved survival in stage IV breast cancer patients.
Blanchard DK; Shetty PB; Hilsenbeck SG; Elledge RM
Ann Surg; 2008 May; 247(5):732-8. PubMed ID: 18438108
[TBL] [Abstract][Full Text] [Related]
10. Gender Disparity in Breast Cancer: A Veteran Population-Based Comparison.
Aggarwal A; Adepoju B; Yacur M; Maron D; Sharma MC
Clin Breast Cancer; 2021 Aug; 21(4):e471-e478. PubMed ID: 33619003
[TBL] [Abstract][Full Text] [Related]
11. [Breast cancer: prognostic value of flow cytometry and hormone receptors. Apropos of a Lebanese series of patients].
Aftimos G; Trak-Smayra V; Moacdieh-Rehayel L
J Med Liban; 2000; 48(1):8-17. PubMed ID: 10881437
[TBL] [Abstract][Full Text] [Related]
12. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant systemic therapy for male breast carcinoma.
Giordano SH; Perkins GH; Broglio K; Garcia SG; Middleton LP; Buzdar AU; Hortobagyi GN
Cancer; 2005 Dec; 104(11):2359-64. PubMed ID: 16270318
[TBL] [Abstract][Full Text] [Related]
14. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome.
Joshi MG; Lee AK; Loda M; Camus MG; Pedersen C; Heatley GJ; Hughes KS
Cancer; 1996 Feb; 77(3):490-8. PubMed ID: 8630956
[TBL] [Abstract][Full Text] [Related]
15. Racial/ethnic differences in survival rates in a population-based series of men with breast carcinoma.
O'Malley CD; Prehn AW; Shema SJ; Glaser SL
Cancer; 2002 Jun; 94(11):2836-43. PubMed ID: 12115370
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA
Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621
[TBL] [Abstract][Full Text] [Related]
17. A population-based study of lung carcinoma in Pennsylvania: comparison of Veterans Administration and civilian populations.
Campling BG; Hwang WT; Zhang J; Thompson S; Litzky LA; Vachani A; Rosen IM; Algazy KM
Cancer; 2005 Aug; 104(4):833-40. PubMed ID: 15973670
[TBL] [Abstract][Full Text] [Related]
18. Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System.
Rabeneck L; Souchek J; El-Serag HB
Am J Gastroenterol; 2003 May; 98(5):1186-92. PubMed ID: 12809847
[TBL] [Abstract][Full Text] [Related]
19. Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis.
Fields RC; Jeffe DB; Trinkaus K; Zhang Q; Arthur C; Aft R; Dietz JR; Eberlein TJ; Gillanders WE; Margenthaler JA
Ann Surg Oncol; 2007 Dec; 14(12):3345-51. PubMed ID: 17687611
[TBL] [Abstract][Full Text] [Related]
20. Triple-negative breast cancer in West Virginia.
Abraham J; Flanagan M; Hazard H; Jubelirer S; Tirona MT; Vona-Davis L
W V Med J; 2009 Oct; 105 Spec No():54-9. PubMed ID: 19999267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
